Please login to the form below

Not currently logged in
Email:
Password:

Parexel appoints chief scientific officer

Promotion for Sy Pretorius
Paraxel Sy Pretorius

Parexel has promoted Dr Sy Pretorius to the position of chief scientific officer.

Dr Pretorius currently serves as worldwide head of early phase development at the contract research organisation (CRO) and will continue in that role in addition to his new duties.

These responsibilities include enhancing and leading the innovation of clinical research methodologies and helping Parexel to meet client demands. Key priorities include clinical trial modelling and simulations and adaptive trial designs.

Dr Pretorius knows the needs of Parexel well have spent nearly 18 years at the company. During this time he has served in a variety of positions, including corporate VP, clinical pharmacology in North America.

Parexel's president and chief operating officer Mark Goldberg said: “Pretorius has enjoyed a long and distinguished career at the Company, and applying his expertise more broadly will benefit customers and Parexel alike."

30th May 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...

Infographics